PMC:7408073 / 97540-98031
Annnotations
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T194 | 330-333 | Body_part | denotes | RAS | http://purl.obolibrary.org/obo/UBERON_0018229 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3416 | 57-61 | Gene | denotes | ACE2 | Gene:59272 |
| 3417 | 169-173 | Gene | denotes | ACE2 | Gene:59272 |
| 3418 | 51-56 | Species | denotes | human | Tax:9606 |
| 3419 | 156-161 | Species | denotes | human | Tax:9606 |
| 3420 | 359-367 | Species | denotes | patients | Tax:9606 |
| 3421 | 347-355 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T547 | 347-355 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1194 | 13-20 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | focused |
| T1195 | 21-23 | http://purl.obolibrary.org/obo/CLO_0050475 | denotes | my |
| T1196 | 51-56 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T1197 | 156-161 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T1198 | 240-241 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T25711 | 37-47 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T33721 | 174-192 | Chemical | denotes | pathway inhibitors | http://purl.obolibrary.org/obo/CHEBI_76932 |
| T20781 | 182-192 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T88121 | 330-333 | Chemical | denotes | RAS | http://purl.obolibrary.org/obo/CHEBI_63620 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T473 | 0-114 | Sentence | denotes | Here, I have focused my attention on inhibitors of human ACE2 pathway that were consistently administered in vivo. |
| T474 | 115-491 | Sentence | denotes | Making use of published reports in which human/rodent ACE2 pathway inhibitors were administered in vivo, I have hypothesized a possible therapeutic pharmacological intervention through an inhibition strategy of the RAS pathways for COVID-19 in patients experiencing both mild and critical, advanced and untreatable stages of the disease (the most problematic cases to manage). |